IG

Igraine plc

Invests in and develops breakthrough tech in battery energy storage and life sciences.

Aquis Stock Exchange

Overview

Corporate Details

ISIN(s):
GB00BM9CKV18
LEI:
213800VX2NIA6TZN3I39
Country:
United Kingdom
Address:
C/O HILL DICKINSON LLP, EC2A 2EW LONDON
Sector:
Financial and insurance activities
Industry:
Other financial service activities, except insurance and pension funding activities

Description

Igraine plc is an investment company focused on sourcing and developing businesses with breakthrough technologies, primarily in the battery energy storage and life sciences sectors. The company's strategy is to identify commercially attractive discoveries and invest through methods such as acquiring controlling shareholdings or providing secured convertible loan notes. Its life sciences portfolio includes innovations in healthcare and medical technology. Igraine plc leverages over 30 years of scientific experience and global expertise to guide its investment decisions and support the growth of its portfolio companies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-06 17:10
Major Shareholding Notification
Igraine Plc - Holding(s) in Company
English 98.9 KB
2025-09-26 11:13
Earnings Release
Igraine Plc - Interim Results for the Half-Year to 30 June 2025
English 101.7 KB
2025-09-02 09:59
Major Shareholding Notification
Igraine Plc - Holding(s) in Company
English 33.5 KB
2025-08-05 08:00
Regulatory News Service
Igraine Plc - Investee Update: Collaboration Agreement with Homerun Resources I…
English 11.4 KB
2025-07-16 08:00
Board/Management Information
Igraine Plc - Investee Update: Fixit Medical Ltd
English 11.9 KB
2025-06-27 13:42
Annual / Quarterly Financial Statement
Igraine Plc - Financial Statements for the Year Ended 31 December 2024
English 671.6 KB
2025-06-23 08:00
Regulatory News Service
Igraine Plc - Investee Update: Fixit Medical Ltd
English 15.2 KB

Automate Your Workflow. Get a real-time feed of all Igraine plc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Igraine plc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
MANOLETE PARTNERS PLC Logo
A specialist firm financing and acquiring insolvency claims to maximize creditor returns.
United Kingdom MANO
Marfin Investment Group S.A. Logo
Investment holding firm acquiring equity stakes in diverse sectors and commercial real estate.
Greece MIG
Mashup Ireland AB Logo
Principal investment group funding and growing underserved Irish SMEs and property assets.
Sweden MASHUP
MCI Capital Alternatywna Spółka Inwestycyjna S.A. Logo
A Central European private equity firm investing in digital and climatech growth companies.
Poland MCI
MedCap Logo
A private equity firm acquiring and developing niche life science companies in Northern Europe.
Sweden MCAP
Medical Devices Venture SA Logo
Invests in MedTech & Health Tech start-ups to commercialize research for better patient care.
France MLMDV
Merchavia Holdings and Investments Ltd. Logo
An investment holding company specializing in Med-Tech, biomedical, and life sciences ventures.
Israel MRHL
Méthanor Logo
Finances and operates a diverse portfolio of renewable energy projects in France.
France ALMET
An R&D partnership investing in and developing emerging food-tech companies with sustainable solutions.
Israel N/A
Mittel Logo
Italian investment firm investing in SMEs via Private Equity and in Real Estate.
Italy MIT

Talk to a Data Expert

Have a question? We'll get back to you promptly.